R. Lever

415 total citations · 1 hit paper
10 papers, 278 citations indexed

About

R. Lever is a scholar working on Surgery, Molecular Biology and Cell Biology. According to data from OpenAlex, R. Lever has authored 10 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in R. Lever's work include Heparin-Induced Thrombocytopenia and Thrombosis (6 papers), Cell Adhesion Molecules Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). R. Lever is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (6 papers), Cell Adhesion Molecules Research (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). R. Lever collaborates with scholars based in United Kingdom and United States. R. Lever's co-authors include Clive Page, Barbara Mulloy, Victoria Boswell‐Smith, Neil A. Jones, Elaine Gray, John Hogwood, J. Gallagher, William Paul, Oliver Floßmann and David Jayne and has published in prestigious journals such as Pharmacological Reviews, British Journal of Pharmacology and Clinical & Experimental Allergy.

In The Last Decade

R. Lever

10 papers receiving 270 citations

Hit Papers

Pharmacology of Heparin and Related Drugs: An Update 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Lever United Kingdom 6 115 70 66 65 56 10 278
Johanna Busse Germany 6 166 1.4× 65 0.9× 54 0.8× 33 0.5× 70 1.3× 7 389
W. Hylton United Kingdom 12 76 0.7× 148 2.1× 29 0.4× 44 0.7× 25 0.4× 16 343
A. Jill Mackarel Ireland 7 102 0.9× 102 1.5× 14 0.2× 51 0.8× 139 2.5× 12 345
T. Ochiai Japan 10 114 1.0× 85 1.2× 24 0.4× 82 1.3× 31 0.6× 16 364
Kristin N. Kornerup United Kingdom 6 134 1.2× 163 2.3× 19 0.3× 52 0.8× 60 1.1× 6 437
Kristoffer Larsen Sweden 9 100 0.9× 56 0.8× 42 0.6× 140 2.2× 229 4.1× 17 401
Yoshitaka Kuwahara Japan 10 280 2.4× 76 1.1× 21 0.3× 26 0.4× 63 1.1× 22 437
Bettina Oehrle Germany 4 97 0.8× 34 0.5× 51 0.8× 52 0.8× 197 3.5× 8 401
Emily K. Thomas United States 11 281 2.4× 41 0.6× 40 0.6× 23 0.4× 69 1.2× 20 527
Ru-Hua Zhang China 11 224 1.9× 57 0.8× 21 0.3× 49 0.8× 38 0.7× 12 564

Countries citing papers authored by R. Lever

Since Specialization
Citations

This map shows the geographic impact of R. Lever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Lever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Lever more than expected).

Fields of papers citing papers by R. Lever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Lever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Lever. The network helps show where R. Lever may publish in the future.

Co-authorship network of co-authors of R. Lever

This figure shows the co-authorship network connecting the top 25 collaborators of R. Lever. A scholar is included among the top collaborators of R. Lever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Lever. R. Lever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hogwood, John, Barbara Mulloy, R. Lever, Elaine Gray, & Clive Page. (2023). Pharmacology of Heparin and Related Drugs: An Update. Pharmacological Reviews. 75(2). 328–379. 65 indexed citations breakdown →
3.
Mulloy, Barbara, R. Lever, & Clive Page. (2016). Mast cell glycosaminoglycans. Glycoconjugate Journal. 34(3). 351–361. 56 indexed citations
4.
Lever, R., et al.. (2007). Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses. Clinical & Experimental Allergy. 37(6). 909–917. 5 indexed citations
5.
Lever, R., et al.. (2007). Size‐fractionated heparins have differential effects on human neutrophil function in vitro. British Journal of Pharmacology. 151(6). 837–843. 26 indexed citations
6.
Jones, Neil A., Victoria Boswell‐Smith, R. Lever, & Clive Page. (2004). The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro. Pulmonary Pharmacology & Therapeutics. 18(2). 93–101. 82 indexed citations
7.
Lever, R., et al.. (2003). The effects of heparin fractions of defined chain length on human neutrophil functions in vitro. British Journal of Pharmacology. 140. 2 indexed citations
8.
Lever, R. & Clive Page. (2001). Glycosaminoglycans, Airways Inflammation and Bronchial Hyperresponsiveness. Pulmonary Pharmacology & Therapeutics. 14(3). 249–254. 38 indexed citations
9.
Page, Clive, et al.. (1999). Effects of heparin upon adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein cells and adhesion molecule expression in vitro. British Journal of Pharmacology. 128. 1 indexed citations
10.
Lever, R., et al.. (1999). Effects of heparinases and heparin upon the adhesive functions and surface characteristics of human umbilical; Vein endothelial cells. 126. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026